Education

Timely Topics in Transplantation

Timely Topics in Transplantation webinars are the perfect opportunity to listen to a live presentation on a current issue and ask questions directly to the presenter. All webinars are available on demand after the live air date. 

How to Register for an Individual Webinar
Pre-registration is required for each webinar in order to receive reminders and access instructions on the day of the webinar. Click "Register" under any webinar below and you will be taken to the AST digital library website. On that website, click the "Register" link to add the webinar to your cart and proceed to checkout.

AST MEMBERS: To remove the $25 fee, simply log in with your AST username and password and the charge will change to $0.
NON-MEMBERS: If you have an account on the AST website, sign in with those credentials. If you do not have an account with AST, create an account and proceed with the purchase (your account will not be an AST website account nor a membership account; it is your webinar access account).

Short Term Support for Failing Patients: Role of VV and VA ECMO

Wednesday, May 1, 2019 - 2:00 pm to 3:00 pm EDT

Register

Speaker: Francis Pagani, MD, PhD • University of Michigan
Moderator: David Baran, MD • Sentara Heart Hospital

After participating in this webinar, the learner will be able to:

  1. Describe appropriate clinical use including and understand the indications and contraindications for use of VV or VA ECMO.
  2. Understand the hemodynamic effects of ECMO support and impact on left ventricular emptying and its potential for vascular complications.
  3. Understand the general technology of the ECMO circuit.
  4. Describe benefits and limitations relative to other forms of temporary mechanical circulatory support.

Archived Webinars

Pharmacogenomics

Wednesday, April 17, 2019 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker:
Pamala Jacobson, PharmD • University of Minnesota College of Pharmacy

Moderator:
Cyrine Haidar, Pharm.D., BCPS, BCOP • St. Jude Children's Research Hospital

After participating in this webinar, the learner will be able to:

  1. Summarize the key pharmacogenomic findings in kidney transplantation.
  2. Understand how pharmacogenomics could be used in delivery of transplant care.
  3. Outline the limitations of the pharmacogenomic information.

 

Case-Based Multidisciplinary Approach to Cardiac and Pulmonary Vascular Disease Risk Assessment in Liver Transplantation

Wednesday, March 20, 2019 - 2:00 pm to 3:00 pm EDT

View Archive

Speakers:
Lisa VanWagner, MD, MSc, FAST, FAHA • Northwestern Medicine
Marina Serper, MD, MS • University of Pennsylvania
Christopher Darling, DO • University of Wisconsin

Moderator:
Shelley Hall, MD, FAST • Baylor University Medical Center - Dallas

After participating in this webinar, the learner will be able to:

  1. Construct an evidence-based plan for the assessment of cardiovascular risk in the liver transplant candidate.
  2. Explain the diagnostic criteria for portopulmonary hypertension, treatment strategies to improve liver transplant candidacy and intraoperative management considerations.
  3. Discuss management approaches for the leading perioperative cardiovascular complications (e.g., atrial fibrillation, congestive heart failure and stroke) in liver transplant recipients.

Which Live Donor Kidney is Better?

Wednesday, February 20, 2019 - 2:00 pm to 3:00 pm EST

View Archive

Q&A Handout: Covering speaker responses to questions not addressed during the live session.

Speakers:
Peter Reese, MD, MSCE • University of Pennsylvania School of Medicine
John Gill, MD, MS, FAST • University of British Columbia

Moderator:
Didier Mandelbrot, MD • University of Wisconsin Health

After participating in this webinar, the learner will be able to:

  1. Identify potential benefits and hazards of “grading” living donors for the transplant candidate.
  2. Understand useful applications and limitations of living donor risk calculators.
  3. Identify appropriate scenarios in which to consider alternative living donors, with a focus on paired exchange.

 

Optimizing Informed Consent Processes to Educate Donor and Recipient Candidates about Psychosocial Risks

Wednesday, January 16, 2019 - 2:00 pm to 3:00 pm EST

View Archive

Q&A Handout: Covering speaker responses to questions not addressed during the live session.

Speaker: Rebecca Hays, MSW • University of Wisconsin Department of Coordinated Care
Moderator: Jim Rodrigue, PhD • Beth Israel Deaconess Medical Center

After participating in this webinar, the learner will be able to:

  1. Outline elements of a meaningful informed consent process and content elements prescribed by the OPTN.
  2. Review psychosocial outcomes and risk factors for poor outcomes (psychological and financial) for transplant recipients and living donors.
  3. Describe best practices to promote understanding, including use of teach back, plain language, and culturally relevant approaches.

Building Blocks of a Transplant QAPI Plan

Wednesday, December 12, 2018 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Linda Ohler, MSN, RN, CCTC, FAAN, FAST • New York University Langone Transplant Institute
Moderator: Marian O'Rourke, RN, BSN, CCTC • Jackson Memorial Hospital

After participating in this webinar, the learner will be able to:

  1. Identify the purpose of a QAPI Plan designed for transplant teams
  2. Discuss the relationship between the transplant QAPI Plan and the hospital QAPI Plan
  3. Describe key concepts to include in a transplant QAPI Plan
  4. Identify resources available to transplant personnel when writing a comprehensive quality plan. 

Psychosocial Aspects of Transition of the Newly Adult, New Patient

Wednesday, November 28, 2018 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Beverly Kosmach-Park, DNP, RN, FAAN • Children's Hospital of Pittsburgh
Moderator: Sandra Amaral, MD, MHS • Children's Hospital of Philadelphia

After participating in this webinar, the learner will be able to:

  1. Provide a summary of neurocognitive and developmental issues specific to the late adolescent/young adult transplant recipient transitioning to adult care.

  2. List common transition barriers encountered by pediatric and adult providers.

  3. Identify essential components of transition, including a transition policy and readiness assessment.

  4. Discuss strategies to help the adult provider successfully engage with the newly transitioned young adult transplant recipient.

  5. Discuss the value and challenges of measuring outcomes following transfer from both the pediatric and adult perspective.

Transplant Metrics - Should We Enforce or Rewrite the Final Rule?

Wednesday, November 14, 2018 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Jesse Schold, PhD, M.Stat, M.Ed • Cleveland Clinic
Moderator: Anil Chandraker, MD, FAST, FRCP • Brigham and Women's Hospital

After participating in this webinar, the learner will be able to:

  1. Understand the current system for identifying transplant center performance under the final rule.
  2. Evaluate the current evidence of the effects of the Final rule in the field of transplantation.
  3. Consider the benefits and limitations of revising the final rule.
     

Significance, Identification, and Treatment of Post-Thoracic Transplant Circulating Antibodies

Wednesday, October 31, 2018 - 2:00 pm to 3:00 pm EDT

VIEW ARCHIVE

Speakers:
Ramsey Hachem, MD • Washington University School of Medicine
Deborah Jo Levine, MD • University of Texas Health Science Center

Moderator: Sangeeta Bhorade, MD • Northwestern University

 

Family Planning in SOT

Wednesday, October 10, 2018 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Lisa Coscia, RN, BSN, CCTC • Transplant Pregnancy Registry International
Moderator: Monika Sarkar, MD, MAS • University of California, San Francisco

After participating in this webinar, the learner will be able to:

  1. Discuss the effect of end organ disease and subsequent transplant on fertility in women.
  2. Review the safety and efficacy of hormonal contraceptive options in transplant recipients.
  3. Discuss pre-conception recommendations for transplant recipients, including timing and immunosuppression management.
  4. Review maternal and fetal outcome data in both transplant recipients and living organ donors.
  5. Provide resources for additional patient and provider education on reproductive health after transplantation.

Achieving Immune Tolerance through Hematopoietic Mixed Chimerism in Deceased Donation

Thursday, September 20, 2018 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: David H. Sachs, MD • CUMC & MGH/HMS
Moderator: Sebastian Eriksson Giwa, PhD • Ossium Health and Sylvatica Biotech

After participating in this webinar, the learner will be able to:

  1. Explain the advantages of tolerance vs. immune suppression.
  2. Evaluate the overall status of clinical transplant tolerance and the protocols used in trials.
  3. Identify current limitations to immune tolerance protocols.
  4. Identify potential solutions through the use of organ and cell preservation technologies.
  5. Evaluate the protocols in trials and the overall status of clinical transplant tolerance.

Epigenetic Modifications of Immune Cells and their Importance for Alloimmunity

Wednesday, September 12, 2018 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Andrew Wells, PhD • University of Pennsylvania and CHOP
Moderator: Jonathan Maltzman, MD, PhD • Stanford University

After participating in this webinar, the learner will be able to:

  1. Define epigenetics, outline basic concepts and processes.
  2. Outline examples of DNA methylation controlling T cell function.
  3. Outline examples of histone modifications controlling T cell function.
  4. Describe examples of epigenetic factors contributing to organ transplant rejection in rodent models.
  5. Describe a clinical example of epigenetic drug targeting in allogenic bone marrow transplantation to alleviate GVHD.
  6. Outline basic concepts in genomics and epigenomics.
  7. Describe 3-dimensional regulatory architectures of inflammatory genes in T cells.
  8. Discuss the use of 3D epigenomics to understand the basis of genetic susceptibility to inflammatory disease in humans.

Respiratory Viral Infections in Lung Transplantation

Thursday, June 21, 2018 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Cynthia Fisher, MD, MPH • University of Washington
Moderator: Sangeeta Bhorade, MD • Northwestern University

After participating in this webinar, the learner will be able to:

  1. Describe the incidence and clinical impact of respiratory viruses (RVs) in lung transplant recipients (LTR).
  2. Explain the evidence linking RVI to chronic lung allograft dysfunction (CLAD).
  3. List currently available and promising investigational therapies for: RSV, Influenza, and PIV.
  4. Discuss prevention strategies.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.